Libifem® (Fenugreek for Female Libido)

Trigonella foenum-graecum
Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Libifem® is a standardized fenugreek seed extract (the Fenuside™ furostanol saponin fraction) sold by Saanroo, formerly Gencor Pacific, and marketed for female libido and sexual function. It uses the same standardization as Testofen®, but the two products have never been compared head to head, so Testofen® studies in men are not evidence for Libifem® in women. Its main support is a double-blind, randomized, placebo-controlled trial in 80 healthy menstruating women aged 20 to 49 who reported low sexual drive: 600 mg a day over two menstrual cycles, about 8 weeks, improved sexual desire and arousal on the DISF-SR questionnaire and raised free testosterone and estradiol compared with placebo. All three published Libifem trials come from the same manufacturer-linked research group, and no independent team has repeated them.

Studied Dose 600 mg a day, the dose used in all three published Libifem trials. A 300 mg dose was tested in the exercise trial and did not beat placebo.
Active Compound Furostanol saponins (Fenuside™ standardized fraction) from fenugreek seeds

Benefits

Female Sexual Desire / Vitality

In a double-blind, randomized, placebo-controlled trial, 80 healthy menstruating women aged 20 to 49 who reported low sexual drive took 600 mg a day for two menstrual cycles, about 8 weeks. Sexual desire and arousal scores on the DISF-SR questionnaire improved significantly more than with placebo, and free testosterone and estradiol also rose. The study came from a research group tied to the ingredient supplier and has not been repeated independently.

Menopause Symptoms (Studied in Women Aged 40 to 65)

A separate 12-week trial in 115 otherwise healthy menopausal women aged 40 to 65 taking 600 mg a day reported fewer hot flushes and night sweats and better menopause-related quality of life than placebo. These were different women from the libido trial, and the published abstract describes a proprietary de-husked fenugreek seed extract without naming Libifem. Sexual symptoms improved as well, but only as one section of a general menopause questionnaire rather than a dedicated sexual function test.

Female Resistance Training Strength

In a placebo-controlled trial in women aged 25 to 45 who all followed the same whole-body exercise program three times a week, only the 600 mg a day group gained significantly more leg-press strength, lean mass and fat loss than placebo. The 300 mg dose was no better than placebo. Libido and hormones were not measured in this study, and the researchers disclosed an industry link.

Hormonal Balance Mechanism

In the 80-woman libido trial, 600 mg a day significantly raised free testosterone and estradiol compared with placebo. The usual explanation is that fenugreek saponins change how much of these hormones circulate free rather than bound to the carrier protein SHBG, but that trial measured hormone levels only, not SHBG binding, so the mechanism is still a proposal.

Well-Tolerated

Across the published trials, which ran 8 to 12 weeks, side effects were mild and broadly similar to placebo. Long-term safety beyond 12 weeks has not been studied.

Mechanism of action

1

Furostanol Saponin Hormonal Modulation

The proposed mechanism is that fenugreek furostanol saponins shift how much testosterone and estradiol circulate free rather than bound to the carrier protein SHBG. In women, the brand trial did show higher free testosterone and estradiol after 600 mg a day, but SHBG binding itself was never measured, so this stays a working explanation rather than a demonstrated pathway.

2

Female Sexual Desire Multifactorial

Female sexual desire involves estradiol and testosterone, psychological factors, relationship quality, hormonal cycle, age. Libifem appears to act on the hormonal part of that picture only, so individual results vary.

3

Possible Effects on Strength and Body Composition

The strength and body composition results in women come from one Libifem trial at 600 mg a day alongside a supervised exercise program, not from studies of other fenugreek brands in men. How the extract produces those changes has not been established.

4

Standardized Fenuside Saponins

Libifem is standardized to a set level of furostanol saponins, which helps keep batches consistent. It shares a standardization name with Testofen, but no head-to-head study has compared the two products, so their results should not be treated as interchangeable.

Clinical trials

1
Libifem for Female Sexual Function

Double-blind, randomized, placebo-controlled trial of Libifem 600 mg a day versus placebo over two menstrual cycles, about 8 weeks (Rao 2015, Phytotherapy Research). Participants were 80 healthy menstruating women.

80 healthy menstruating women.

All participants were aged 20 to 49 and reported low sexual drive at the start. Sexual desire and arousal scores on the DISF-SR questionnaire improved significantly versus placebo, and free testosterone and estradiol rose. Relationship quality and general quality of life were not reported outcomes of this trial. The authors are linked to the ingredient supplier, and no independent group has repeated the study.

2
Libifem for Female Resistance Training

Randomized, placebo-controlled trial of Libifem 300 mg or 600 mg a day in women aged 25 to 45. Everyone in the study, including the placebo group, followed the same whole-body exercise program three times a week, so exercise was controlled background rather than something only the supplement group received.

Women aged 25 to 45, all following the same supervised exercise program.

Only the 600 mg a day group did significantly better than placebo, gaining more leg-press strength and lean mass and losing more fat. The 300 mg dose was no better than placebo. Libido and hormones were not measured here, and the researchers disclosed an industry link.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress.
Maple syrup-like body odor (fenugreek).
May lower blood sugar modestly.
Allergic reactions to fenugreek (legume) — peanut/soy/chickpea cross-reactivity.
May mildly slow blood clotting.

Important Drug interactions

Diabetes medications — additive hypoglycemic effects.
Anticoagulants — modest bleeding risk.
Oral contraceptives — theoretical interactions.
HRT — theoretical interactions; consult.
Pregnancy — fenugreek contraindicated.
Hormone-sensitive cancers — consult.
Pre-surgery — discontinue 1-2 weeks.

Frequently asked questions about Libifem® (Fenugreek for Female Libido)

What is Libifem?

Libifem® is a standardized fenugreek seed extract (the Fenuside™ furostanol saponin fraction) sold by Saanroo, formerly Gencor Pacific, and marketed for female libido and sexual function.

What is Libifem used for?

Libifem is researched primarily for Women's Health and Libido Support. In a double-blind, randomized, placebo-controlled trial, 80 healthy menstruating women aged 20 to 49 who reported low sexual drive took 600 mg a day for two menstrual cycles, about 8 weeks.

What is the recommended dosage of Libifem?

The clinically studied dose is 600 mg a day, the dose used in all three published Libifem trials. A 300 mg dose was tested in the exercise trial and did not beat placebo. Always follow the product label and check with a healthcare provider for personal advice.

Is Libifem safe, and does it have side effects?

For most healthy adults, Libifem is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. Mild GI distress. It may also interact with some medications. Libifem is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Libifem interact with any medications?

Possible interactions include: Diabetes medications — additive hypoglycemic effects. Anticoagulants — modest bleeding risk. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Libifem?

NutraSmarts rates the evidence for Libifem as Moderate (3 out of 5). It is backed by 2 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Steels E, Steele ML, Harold M, Coulson S. Efficacy of a Proprietary Trigonella foenum-graecum L. De-Husked Seed Extract in Reducing Menopausal Symptoms in Otherwise Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Study. Phytother Res. 2017;31(9):1316-1322. doi: 10.1002/ptr.5856.PubMedUsed to support: In 115 healthy women aged 40-65, this industry-sponsored 12-week RCT of the proprietary de-husked fenugreek seed extract, which the published abstract does not identify as Libifem, at 600 mg/day significantly reduced hot flushes and night sweats and improved MENQOL scores versus placebo, backing the menopausal/vasomotor-symptom claim; authored by parties tied to the sponsor.
  2. Rao A, Clayton P, Briskey D. Libifem (Trigonella foenum-graecum) in conjunction with exercise on muscle strength, power, endurance, and body composition in females aged between 25 and 45 years. Front Sports Act Living. 2023;5:1207013. doi: 10.3389/fspor.2023.1207013.PubMedUsed to support: Small placebo-controlled RCT in women aged 25-45 testing Libifem at 300 and 600 mg/day with resistance training; only the 600 mg group showed significantly greater leg-press strength, fat loss, and lean-mass gains, supporting strength/body-composition (not libido) claims, with mixed dose effects and an industry-linked CRO conflict disclosed.
  3. Rao A, Steels E, Beccaria G, Inder WJ, Vitetta L. Influence of a Specialized Trigonella foenum-graecum Seed Extract (Libifem), on Testosterone, Estradiol and Sexual Function in Healthy Menstruating Women, a Randomised Placebo Controlled Study. Phytother Res. 2015;29(8):1123-30..PubMedUsed to support: Double-blind, randomised, placebo-controlled trial of Libifem 600 mg daily for two menstrual cycles in 80 healthy menstruating women aged 20 to 49 with low sexual drive; improved sexual desire and arousal, and raised free testosterone and estradiol.